This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Obstructive Uropathy Treatment Market

Obstructive Uropathy Treatment Market By Product Type (Nephro-Ureterostomy Catheter, Ureteral Stents), End User (Hospitals, Ambulatory Surgical Centers) & Region - Forecast 2022-2032

Market Insights on Obstructive Uropathy Treatment covering sales outlook, demand forecast & up-to-date key trends

Obstructive Uropathy Treatment Market Overview

The global obstructive uropathy treatment market was valued at US$ 5 Billion in FY 2021, and is forecast to incline at a Y-o-Y valuation of 5.6% to reach a valuation of US$ 5.3 Billion in 2022. During the 2022-2032 forecast period, the market is poised to expand at a 5.2% value CAGR to reach US$ 8.8 Billion.

Report Attribute

Details

Estimated Base Year Value (2021)

US$ 5 Billion

Expected Market Value (2022)

US$ 5.3 Billion

Anticipated Forecast Value (2032)

US$ 8.8 Billion

Projected Growth Rate (2022-2032)

5.2% CAGR

Obstructive uropathy is an obstruction and hindrance in the urinal tract that causes complete or partial obstructions to the normal flow of urine. Obstructive uropathy is caused by a structural or functional malfunction that prevents urine drainage and can lead to serious complications if not treated. Obstructive uropathy can be either acute or chronic.

Obstructive uropathy treatment is appropriate for people of all ages because it can affect anyone at any age. Obstructive uropathy accounts for 10% of the causes of acute renal failure and 4% of cases of chronic end-stage renal failure. Obstructive uropathy can be caused by a neoplastic condition, inflammation, or it can be inherited.

Treatment for obstructive uropathy entails inserting catheters or stents into the kidney or ureter to restore normal urine flow. The treatment for obstructive uropathy is minimally invasive and has a high success rate. The nephron-ureterostomy catheter is inserted through the skin and allows urine to flow from the bladder to the renal pelvis.

A ureteral stent is a tube that is implanted in the ureter and allows urine to flow from the kidney to the bladder. Hydronephrosis is a condition in which there is an excess of fluid in the kidney that is treated with obstructive uropathy. Prompt obstruction relief by the obstructive uropathy treatment market usually results in the preservation of kidney function.

Which are Some Prominent Drivers Spearheading Obstructive Uropathy Treatment Market Growth?

The rising prevalence of kidney stones as a result of changing lifestyles is driving the growth of the global obstructive uropathy treatment market. Furthermore, the rising incidence of cancer and postoperative infection in kidney transplant recipients drives the growth of the obstructive uropathy treatment market.

Over the forecast period, the rising prevalence of hydro nephrosis in the population is expected to create a high demand for obstructive uropathy treatment. The increasing number of manufacturers and distributors of catheters and stents for obstructive uropathy treatment is increasing the regional availability of the products in underserved regions and fueling the market for obstructive uropathy treatment.

Because of the increasing adoption of the products by end-users, the global obstructive uropathy treatment market is expected to grow significantly over the forecast period. An autopsy series of 59,064 subjects ranging in age from infants to geriatric people revealed that 3.1 percent were positive for hydronephrosis, and this figure is expected to rise further, propelling demand for the obstructive Uropathy market.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Challenges Faced by the Obstructive Uropathy Treatment Industry?

Surgery to remove the obstruction or place a stent can have side effects such as discomfort and an increased risk of infection, which can hamper market growth slightly.

Why is North America Emerging as an Opportunistic Obstructive Uropathy Treatment Market?

Because of the region's high prevalence of urological disorders and higher healthcare expenditure, North America is expected to be the market leader in global obstructive uropathy treatment. Because of the increasing prevalence of kidney stones in this region, North America is expected to hold a significant market share in the global uropathy treatment market.

According to a study published in the Clinical Journal of the American Society of Nephrology, one in every eleven people in the United States will develop a urinary stone during their lifetime. Furthermore, the prevalence of urinary stone disease in children is increasing year after year, particularly among adolescents. Furthermore, technological advancements and new product launches, as well as the presence of a well-established healthcare infrastructure, are fueling the overall regional market's growth to a large extent.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is Europe Contributing to the Growth of the Obstructive Uropathy Treatment Market?

Due to higher healthcare spending and greater adoption by end-users in the region, the Europe obstructive uropathy treatment market is expected to account for the second-largest share in the obstructive uropathy treatment market over the forecast period. The market for obstructive uropathy treatment is expected to grow at a rapid CAGR over the forecast period, owing to increased manufacturer presence and end-user adoption.

Market Competition

Some of the major players identified in the global obstructive uropathy treatment market are Boston Scientific Corporation, Olympus Corporation, Teleflex Incorporated, B. Braun Melsungen AG, Applied Medical, AngioDynamics, Merit Medical Systems, Inc., Argon Medical Devices, Inc., optimed, Cook Medical, Teleflex Incorporated, B. Braun Melsungen AG, and C. R. Bard amongst others.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 5.2% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2015-2020

Forecast Period

2022-2032

Quantitative Units

Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Product Type
  • End User
  • Region

Regions Covered

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • Germany
  • Italy
  • Spain
  • U.K
  • France
  • BENELUX
  • Nordics
  • Australia & New Zealand
  • China
  • India
  • GCC
  • South Africa

Key Companies Profiled

  • Boston Scientific  Corporation
  • Olympus  Corporation
  • Teleflex Incorporated
  • B. Braun Melsungen AG
  • Applied Medical
  • AngioDynamics
  • Merit Medical Systems

Customization

Available Upon Request

Key Segments Covered in the Obstructive Uropathy Treatment Market Report

By Product Type:

  • Nephro-Ureterostomy Catheter-based Obstructive Uropathy Treatment
  • Ureteral Stents-based Obstructive Uropathy Treatment
    • Open-End Stents
    • Closed-End Stents
    • Double Pigtail Stents
    • Multi-Loop Stents

By End Users:

  • Obstructive Uropathy Treatment in Hospitals
  • Obstructive Uropathy Treatment in Ambulatory Surgical Centers
  • Obstructive Uropathy Treatment for Other End Users

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East and Africa

Frequently Asked Questions

FMI projects the global Obstructive Uropathy Treatment market to expand at a 5.2% value CAGR by 2032.

North America is expected to be the most opportunistic Obstructive Uropathy Treatment market.

Some of the major players identified in the global obstructive uropathy treatment market are Boston Scientific Corporation, Olympus Corporation, Teleflex Incorporated, B. Braun Melsungen AG, Applied Medical, AngioDynamics, Merit Medical Systems, Inc., Argon Medical Devices.

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Obstructive Uropathy Treatment Market